PIERIS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1552 USD | -1.18% |
|
-11.96% | -14.67% |
| Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
| Mar. 29 | Pieris Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Pieris Pharmaceuticals, Inc.
77e865d.ZtLFOe_J2IXpQSTmmHR2AHwFgkzKPRJXJGIEhkzWqhM.CrScVda6l_ORA2XR2kIDbwhawGGuUnUvfAN86SiG3FcUtPZtofyU1IMKFA~959211e7a7f657c1a080b25d0143c421
Past events on Pieris Pharmaceuticals, Inc.
| 2024-03-26 | Q4 2023 Earnings Release (Projected) |
| 2023-06-21 08:00 am | Annual General Meeting |
| 2023-06-09 10:00 am | Jefferies Global Healthcare Conference |
| 2023-05-10 08:00 am | Q1 2023 Earnings Call |
| 2023-05-10 07:00 am | Q1 2023 Earnings Release |
| 2023-04-17 01:30 pm | American Association for Cancer Research Meeting |
| 2023-03-29 08:00 am | Q4 2022 Earnings Call |
| 2023-03-29 07:00 am | Q4 2022 Earnings Release |
| 2022-12-01 12:10 pm | Evercore ISI HealthCONx Conference |
| 2022-11-02 08:00 am | Q3 2022 Earnings Call |
| 2022-11-02 07:00 am | Q3 2022 Earnings Release |
| 2022-09-14 12:30 pm | H.C. Wainwright Global Investment Conference |
| 2022-09-06 02:30 am | European Respiratory Society International Congress |
| 2022-08-04 08:00 am | Interim 2022 Earnings Call |
| 2022-08-04 07:00 am | Interim 2022 Earnings Release |
| 2022-06-22 08:00 am | Annual General Meeting |
| 2022-06-08 08:00 am | Jefferies Healthcare Conference |
| 2022-05-11 08:00 am | Q1 2022 Earnings Call |
| 2022-05-11 07:00 am | Q1 2022 Earnings Release |
| 2022-03-01 08:00 am | FY 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 46,3 29,1 59.03% | 29,2 30,2 -3.12% | 31,4 25,4 23.49% | 25,9 26,6 -2.5% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -27,2 -48,4 43.89% | -33,9 -35,7 5.08% | -51,8 -61,0 14.96% | -43,5 -43,2 -0.52% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,5 -47,0 45.81% | -37,1 -36,5 -1.55% | -45,7 -62,7 27.05% | 0,00 0,00 - |
|
Net income Million USD | Released Forecast Spread | -28,3 -47,0 39.79% | -37,2 -36,9 -1% | -45,7 -55,7 17.87% | -33,3 -34,8 4.39% |
|
EPS USD | Released Forecast Spread | -0,56 -0,76 26.32% | -0,68 -0,68 0% | -0,71 -0,88 19.32% | -0,45 -0,47 4.26% |
| Announcement Date | 12/03/20 | 31/03/21 | 01/03/22 | 29/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,44 2,45 244.02% | 11,0 11,3 -2.8% | 3,70 3,24 14.07% | 5,37 4,51 19.04% | 5,85 6,51 -10.21% | 1,94 3,50 -44.69% | 20,1 4,02 399% | 19,5 7,74 152.07% |
|
EBIT Million USD | Released Forecast Spread | -11,0 -20,1 45.38% | -7,46 -9,11 18.18% | -12,3 -15,5 20.6% | -12,2 -14,0 13.09% | -11,5 -11,3 -2% | -15,5 -14,2 -9.23% | 2,06 -13,6 115.17% | -11,8 -11,4 -3.9% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,53 -21,9 56.47% | -5,10 -2,60 -96.19% | -9,74 -14,4 32.39% | -13,2 -14,2 7.16% | 3,98 -14,5 127.42% | |||
|
Net income Million USD | Released Forecast Spread | -9,53 -19,5 51.09% | -5,10 -8,21 37.85% | -10,3 -14,6 29.35% | -9,74 -12,0 18.62% | -8,10 -9,63 15.88% | -13,2 -14,2 7.16% | 3,98 -11,7 133.93% | -10,8 -9,44 -13.89% |
|
EPS USD | Released Forecast Spread | -0,13 -0,30 56.67% | -0,07 -0,12 39.13% | -0,14 -0,20 30% | -0,13 -0,13 0% | -0,11 -0,13 15.38% | -0,18 -0,19 5.26% | 0,05 -0,16 131.25% | -0,11 -0,11 0% |
| Announcement Date | 01/03/22 | 11/05/22 | 04/08/22 | 02/11/22 | 29/03/23 | 11/05/23 | 10/08/23 | 14/11/23 |
More events
Past sector events for Pieris Pharmaceuticals, Inc.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PIRS Stock
- Calendar Pieris Pharmaceuticals, Inc.
